Screener
Rhythm Pharmaceuticals, Inc. RYTM PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Inventory | 28,651 | 25,753 |
| Prepaid expenses and other current assets | 26,622 | 26,133 |
| Total current assets | 430,090 | 466,916 |
| Property and equipment, net | 1,065 | 1,104 |
| Right-of-use asset | 2,936 | 3,049 |
| Intangible assets, net | 5,106 | 5,319 |
| Restricted cash | 601 | 522 |
| Other long-term assets | 2,518 | 3,286 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s PP&E (net)?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported PP&E (net) of $1.07M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s PP&E (net) changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s PP&E (net) increased by 130.5% year-over-year, from $462K to $1.07M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s PP&E (net) has grown at a -19.1% compound annual growth rate (CAGR), from $3.2M to $1.1M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude